- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/10 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Patent holdings for IPC class A61P 19/10
Total number of patents in this class: 1872
10-year publication summary
|
50
|
31
|
77
|
120
|
105
|
98
|
95
|
103
|
93
|
56
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2703 |
33 |
| Daiichi Sankyo Company, Limited | 1881 |
23 |
| Novartis AG | 10727 |
22 |
| Osaka University | 3384 |
17 |
| The Regents of the University of California | 20015 |
16 |
| Radius Health, Inc. | 96 |
16 |
| Bristol-myers Squibb Company | 4872 |
13 |
| Merck Patent GmbH | 5814 |
12 |
| Boehringer Ingelheim International GmbH | 4645 |
11 |
| Amgen Inc. | 4093 |
11 |
| Chugai Seiyaku Kabushiki Kaisha | 1366 |
11 |
| Kyowa Hakko Kirin Co., Ltd. | 280 |
11 |
| Sanofi | 4081 |
11 |
| Bayer Schering Pharma AG | 381 |
10 |
| Entera Bio Ltd. | 47 |
10 |
| sanofi-aventis | 363 |
10 |
| Société des Produits Nestlé S.A. | 9301 |
9 |
| Wisconsin Alumni Research Foundation | 3891 |
9 |
| Asahi Kasei Pharma Corporation | 133 |
9 |
| Astellas Pharma Inc. | 1083 |
9 |
| Other owners | 1599 |